IMMUNOMEDICS, INC. STOCK OPTION AGREEMENT RECITALSStock Option Agreement • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances • Delaware
IMMUNOMEDICS, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT RECITALSRestricted Stock Unit Issuance Agreement • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances • Delaware
IMMUNOMEDICS, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT RECITALSRestricted Stock Unit Issuance Agreement • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances • Delaware
TERMINATION AGREEMENTTermination Agreement • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New Jersey
This Termination Agreement (this “Agreement”) is entered as of September 7, 2007 between Immunomedics, Inc. (the “Company”) and Eva J. Goldenberg, Deborah S. Goldenberg, Denis C. Goldenberg and Neil A. Goldenberg, the Trustees of the David M. and Hildegard Goldenberg Irrevocable Insurance Trust dated January 21, 1992 (“Trustees”, and together with the Company, the “Parties”).
TERMINATION AGREEMENTTermination Agreement • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New Jersey
This Termination Agreement (this “Agreement”) is entered as of September 7, 2007 between Immunomedics, Inc. (the “Company”) and David M. Goldenberg (“Dr. Goldenberg”, and together with the Company, the “Parties”).
ADDENDUM TO STOCK OPTION AGREEMENTStock Option Agreement • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances
The following provisions are hereby incorporated into, and are hereby made a part of, that certain Stock Option Agreement (the “Option Agreement”) by and between Immunomedics, Inc. (the “Corporation”) and (“Optionee”) evidencing the stock option (the “Option”) granted this day to Optionee under the terms of the Corporation’s 2006 Stock Incentive Plan, and such provisions are effective immediately. All capitalized terms in this Addendum, to the extent not otherwise defined herein, shall have the meanings assigned to them in the Option Agreement.
American Enterprise Park Morris Plains, New Jersey Immunomedics, Inc. FOURTH AMENDMENT Expansion/Extension AgreementExpansion/Extension Agreement • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances
This Fourth Amendment to Lease made as of this day of August 15th 2001 between Baker Properties Limited Partnership, a Connecticut limited partnership, having an office at 485 Washington Avenue, Pleasantville, New York 10570 (“Lessor”) and Immunomedics, Inc., having an office at 300 American Road, Morris Plains, New Jersey 07950 (“Lessee”).
SPLIT-DOLLAR INSURANCE AGREEMENTSplit-Dollar Insurance Agreement • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New Jersey
This Agreement made this 2nd day of April, 1992, among IMMUNOMEDICS, INC., a Delaware corporation, 150 Mt. Bethel Road, Warren, New Jersey 07060 (hereinafter called the “Corporation”), and Eva J. Goldenberg, Deborah S. Goldenberg, Denis C. Goldenberg and Neil A. Goldenberg, the Trustees of the David M. and Hildegard Goldenberg Irrevocable Insurance Trust dated January 21, 1992 (hereinafter called the “Trustees”).
SPLIT-DOLLAR INSURANCE AGREEMENTSplit-Dollar Insurance Agreement • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New Jersey
This Agreement made this 19th day of SEPTEMBER, 1994, among IMMUNOMEDICS, INC., a Delaware Corporation, 300 American Road, Morris Plains, New Jersey 07950 (hereinafter called the “Corporation”), and EVA J. GOLDENBERG, DEBORAH S. GOLDENBERG, DENIS C. GOLDENBERG, NEIL A. GOLDENBERG and LEE R. GOLDENBERG, as Trustees of the DAVID M. GOLDENBERG INSURANCE TRUST dated August 5, 1994 (hereinafter called the “Trustees”).
FIRST ADDENDUMFirst Addendum • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances
THIS FIRST ADDENDUM made as of this 5th day of May 1993 between Baker Properties Limited Partnership, a Connecticut limited partnership, having an office at 485 Washington Avenue, Pleasantville, New York 10570 (“Lessor”) and Immunomedics, Inc., having an office at 300 American Road, Morris Plains, New Jersey 07950 (“Lessee”).
ADDENDUM TO RESTRICTED STOCK UNIT ISSUANCE AGREEMENTRestricted Stock Unit Issuance Agreement • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances
The following provisions are hereby incorporated into, and are hereby made a part of, that certain Restricted Stock Unit Issuance Agreement (the “RSU Agreement”) by and between Immunomedics, Inc. (the “Corporation”) and (the “Participant”) evidencing the Restricted Stock Units awarded on this date to the Participant under the Corporation’s 2006 Stock Incentive Plan, and such provisions shall be effective immediately. Each Restricted Stock Unit shall entitle the Participant to one share of Common Stock upon the vesting of that unit.
SECOND ADDENDUMSecond Addendum • September 13th, 2007 • Immunomedics Inc • In vitro & in vivo diagnostic substances
This Second Addendum made as of this 29th day of March 1995 between Baker Properties Limited Partnership, a Connecticut limited partnership, having an office at 485 Washington Avenue, Pleasantville, New York 10570 (“Lessor”) and Immunomedics, Inc., having an office at 300 American Road, Morris Plains, New Jersey 07950 (“Lessee”).
